Routine self-monitoring of blood glucose

G. Michael Allan; Christina Korownyk; Noah Ivers

Clinical question

What are the pros and cons of routine self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes (T2D) who do not use insulin?

Evidence

Recent meta-analyses^1–3 examined routine SMBG in patients with T2D who do not use insulin.
- -Largest analysis had 26 studies with 5373 patients.¹
- -With SMBG, HbA_1c levels improved 0.21% to 0.31%.^1–3
Only 3 of the trials that compared SMBG with no SMBG were of high quality.¹
- -A 6-month trial (DINAMIC study)⁴ found
  - —SMBG improved HbA_1c by 0.25% (P = .0097) and
  - —no difference in weight, fasting glucose, or gliclazide dose.
- -Two 12-month trials (DiGEM⁵ and ESMON⁶) found no difference in HbA_1c levels, drug initiation, or weight.
Self-monitoring of blood glucose has not been shown to attain a minimum clinically important difference in HbA_1c (≥ 0.5%)⁷ in any meta-analysis or high-quality trial.

Context

Important harms of routine SMBG include worsening of depression scores,^6,8 reduced quality of life,^8,9 and poor value for dollar^9,10; in patients with T2D who do not use insulin, there is also little to no clinical value.
- -This evidence does not apply to patients with T2D who use insulin, patients with T1D, or pregnant patients with gestational diabetes.
Reasons for nonroutine blood glucose testing include
- -having symptoms of hypoglycemia or feeling unwell, as these symptoms often do not correlate well with actual blood sugar levels,¹¹
- -seeing the effects of changes to medication, diet, or lifestyle behaviour on sugar status, and
- -nonroutine circumstances (eg, driving).

Bottom line

Routine SMBG in patients with T2D who do not use insulin has no clinical benefits, is not cost-effective, and reduces the quality of life.

Implementation

The burden of SMBG should be minimized to the amount necessary to inform decision making. For patients with T2D who use only oral medications, routine SMBG rarely leads to changes in management, so discouraging this might benefit patients. Reactive SMBG (eg, in response to symptoms or specific circumstances) remains appropriate. Patients taking medications that can cause hypoglycemia require education on recognizing and managing these symptoms. The National Diabetes Information Clearinghouse website has handouts available (http://diabetes.niddk.nih.gov/dm/pubs/hypoglycemia/index.aspx).

Notes

Tools for Practice articles in Canadian Family Physician are adapted from articles published twice monthly on the Alberta College of Family Physicians (ACFP) website, summarizing medical evidence with a focus on topical issues and practice-modifying information. The ACFP summaries and the series in Canadian Family Physician are coordinated by Dr G. Michael Allan, and the summaries are co-authored by at least 1 practising family physician. Feedback is welcome and can be sent to toolsforpractice{at}cfpc.ca. Archived articles are available on the ACFP website: www.acfp.ca.

Footnotes

This article is eligible for Mainpro-M1 credits. To earn credits, go to www.cfp.ca and click on the Mainpro link.
The opinions expressed in Tools for Practice articles are those of the authors and do not necessarily mirror the perspective and policy of the Alberta College of Family Physicians.

References

↵
1. Clar C,
2. Barnard K,
3. Cummins E,
4. Royle P,
5. Waugh N,
6. Aberdeen Health Technology Assessment Group
. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess 2010;14(12):1-140.
OpenUrl PubMed
1. Allemann S,
2. Houriet C,
3. Diem P,
4. Stettler C
. Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Curr Med Res Opin 2009;25(12):2903-13.
OpenUrl CrossRef PubMed
↵
1. McIntosh B,
2. Yu C,
3. Lal A,
4. Chelak K,
5. Cameron C,
6. Singh SR,
7. et al
. Efficacy of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin: a systematic review and meta-analysis. Open Med 2010;4(2):e102-13. Epub 2010 May 18.
OpenUrl PubMed
↵
1. Barnett AH,
2. Krentz AJ,
3. Strojek K,
4. Sieradzki J,
5. Azizi F,
6. Embong M,
7. et al
. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regime. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab 2008;10(12):1293-47. Epub 2008 May 20.
OpenUrl
↵
1. Farmer A,
2. Wade A,
3. Goyder E,
4. Yudkin P,
5. French D,
6. Craven A,
7. et al
. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007;335(7611):132. Epub 2007 Jun 25.
OpenUrl Abstract/FREE Full Text
↵
1. O’Kane MJ,
2. Bunting B,
3. Copeland M,
4. Coates VE,
5. ESMON study group
. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008;336(7654):1174-7. Epub 2008 Apr 17.
OpenUrl Abstract/FREE Full Text
↵
1. National Institute for Health and Clinical Excellence
. NICE short clinical guideline 87. Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes. London, UK: NICE; 2009. Available from: www.nice.org.uk/nicemedia/pdf/CG87ShortGuideline.pdf. Accessed 2011 Jun 16.
↵
1. Franciosi M,
2. Pellegrini F,
3. De Berardis G,
4. Belfiglio M,
5. Cavaliere D,
6. Di Nardo B,
7. et al
. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001;24(11):1870-7.
OpenUrl Abstract/FREE Full Text
↵
1. Simon J,
2. Gray A,
3. Clarke P,
4. Wade A,
5. Neil A,
6. Farmer A
. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 2008;336(7654):1177-80. Epub 2008 Apr 17.
OpenUrl Abstract/FREE Full Text
↵
1. Cameron C,
2. Coyle D,
3. Ur E,
4. Klarenbach S
. Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin. CMAJ 2010;182(1):28-34. Epub 2009 Dec 21.
OpenUrl Abstract/FREE Full Text
↵
1. Pramming S,
2. Thorsteinsson B,
3. Bendtson I,
4. Binder C
. The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients. J Intern Med 1990;228(6):641-6.
OpenUrl PubMed